BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18378500)

  • 1. When proton pump inhibitors fail.
    Kahrilas PJ
    Clin Gastroenterol Hepatol; 2008 May; 6(5):482-3. PubMed ID: 18378500
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid-related disorders and use of antisecretory medication.
    Lassen AT
    Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216
    [No Abstract]   [Full Text] [Related]  

  • 3. Acid Suppressant Medications in the Neonatal Intensive Care Unit: Strategies for Appropriate Use.
    Rostas SE
    J Perinat Neonatal Nurs; 2017; 31(4):299-302. PubMed ID: 29068849
    [No Abstract]   [Full Text] [Related]  

  • 4. Balancing the risks and benefits of proton pump inhibitors.
    Gill JM; Player MS; Metz DC
    Ann Fam Med; 2011; 9(3):200-2. PubMed ID: 21555747
    [No Abstract]   [Full Text] [Related]  

  • 5. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Frazzoni M; Conigliaro R; Melotti G
    Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 7. Eosinophilic esophagitis in GERD patients: a clinicopathological diagnosis using proton pump inhibitors.
    Molina-Infante J; Ferrando-Lamana L; Fernandez-Bermejo M; Porcel-Carreño S
    Am J Gastroenterol; 2009 Nov; 104(11):2856-7. PubMed ID: 19888246
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 9. Addicted to acid suppression.
    Hanauer SB
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):497. PubMed ID: 19713979
    [No Abstract]   [Full Text] [Related]  

  • 10. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
    Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
    Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antisecretory potential of pantoprasole (sanpraz)].
    Kurilovich SA; Chernosheĭkina LE
    Eksp Klin Gastroenterol; 2008; (7):119-22. PubMed ID: 19334455
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy.
    Okuyama M; Motoyama S; Maruyama K; Sasaki K; Sato Y; Ogawa J
    World J Surg; 2008 Feb; 32(2):246-54. PubMed ID: 18064513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J; Louis E; Persy V; Urbain D
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.
    Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A balancing view: Impedance-pH testing in gerd-limited role for now, perhaps more helpful in the future.
    Shay S
    Am J Gastroenterol; 2009 Nov; 104(11):2669-70. PubMed ID: 19888232
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopy-negative reflux disease: concepts and clinical practice.
    Chey WD
    Am J Med; 2004 Sep; 117 Suppl 5A():36S-43S. PubMed ID: 15478851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncardiac chest pain and proton pump inhibitors.
    Bobba RK; Arsura EL
    Arch Intern Med; 2006 Jan; 166(2):248; author reply 248-9. PubMed ID: 16432099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.